Oxytocin + PT141 (NS) — 0.05 mg/mL (total 2.56 mg) Nasal Spray
A precision-formulated nasal spray combining oxytocin and PT-141 (bremelanotide precursor) for targeted neuromodulatory support. Each 50 mL bottle contains a 0.05 mg/mL concentration, totaling 2.56 mg of active peptide. Delivered intranasally for rapid mucosal absorption, this blend is designed to modulate social, emotional, and sexual response pathways through complementary mechanisms: oxytocin supports social bonding, trust, and calming effects, while PT-141 targets melanocortin receptors implicated in sexual arousal and desire.
Key features:
Dual-action formula: oxytocin plus PT-141 for combined prosocial and prosexual signaling.
Low, precisely measured concentration (0.05 mg/mL) for controlled dosing.
Total peptide content: 2.56 mg per bottle.
Nasal spray delivery for quick onset via mucosal absorption.
Supplied in a convenient, metered pump for repeatable dosing.
Intended use and considerations:
For research or investigational contexts where hormone/peptide modulation is being studied.
Not intended as a substitute for medical diagnosis or prescription treatments.
Use only under appropriate supervision. Individuals with cardiovascular conditions, hypertension, psychiatric disorders, or those taking vasoactive or serotonergic medications should exercise caution and consult a qualified healthcare professional before use.
Potential side effects may include nasal irritation, headache, flushing, changes in blood pressure, or mood alterations.
Storage and handling:
Store refrigerated or per manufacturer guidance to maintain peptide stability.
Keep out of reach of children. Dispose of per local regulations.
For clinicians and researchers: confirm dosing schedule, contraindications, and monitoring protocols consistent with institutional review and regulatory standards before administration.
Oxytocin + PT141 (NS) — 0.05 mg/mL (total 2.56 mg) Nasal Spray
A precision-formulated nasal spray combining oxytocin and PT-141 (bremelanotide precursor) for targeted neuromodulatory support. Each 50 mL bottle contains a 0.05 mg/mL concentration, totaling 2.56 mg of active peptide. Delivered intranasally for rapid mucosal absorption, this blend is designed to modulate social, emotional, and sexual response pathways through complementary mechanisms: oxytocin supports social bonding, trust, and calming effects, while PT-141 targets melanocortin receptors implicated in sexual arousal and desire.
Key features:
Dual-action formula: oxytocin plus PT-141 for combined prosocial and prosexual signaling.
Low, precisely measured concentration (0.05 mg/mL) for controlled dosing.
Total peptide content: 2.56 mg per bottle.
Nasal spray delivery for quick onset via mucosal absorption.
Supplied in a convenient, metered pump for repeatable dosing.
Intended use and considerations:
For research or investigational contexts where hormone/peptide modulation is being studied.
Not intended as a substitute for medical diagnosis or prescription treatments.
Use only under appropriate supervision. Individuals with cardiovascular conditions, hypertension, psychiatric disorders, or those taking vasoactive or serotonergic medications should exercise caution and consult a qualified healthcare professional before use.
Potential side effects may include nasal irritation, headache, flushing, changes in blood pressure, or mood alterations.
Storage and handling:
Store refrigerated or per manufacturer guidance to maintain peptide stability.
Keep out of reach of children. Dispose of per local regulations.
For clinicians and researchers: confirm dosing schedule, contraindications, and monitoring protocols consistent with institutional review and regulatory standards before administration.
